eBook: Increase Time to Market with Precision Dispensing Technology
Discover how to make safe, productive, efficient bioprocessing a reality by exploring the benefits of precision dispensing technology.
Featured
-
Breaking News | Industry News | Promotions & Moves
Frontida BioPharm Names Steven Roese as Vice President, Quality
Frontida BioPharm, Inc., a minority-owned pharmaceutical contract development and manufacturing organization based in Philadelphia and Chicago areas, has appointed Steven Roese as Vice President of Quality. Mr. Roese joins Frontida with over 25 years…Contract Pharma Staff 10.30.20
-
-
Financial Reports
Financial Report: Abbvie
Revenue up 52% in the quarter to $12.9 billion.Contract Pharma Staff 10.30.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Lonza to Manufacture AstraZeneca's COVID-19 Long-Acting Antibody Combination
cGMP manufacturing of the two long-acting antibodies to begin in H1 2021 at Lonza's Portsmouth, NH (USA) site.Contract Pharma Staff 10.30.20
-
Bio News | Breaking News | Drug Development | Facilities | Industry News
-
Breaking News
Syneos Health Agrees to Acquire Synteract
Enhances Syneos Health’s position across the fast-growing small to mid-sized category.Contract Pharma Staff 10.29.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
AB2 Bio and WuXi Biologics Enter Collaboration
Set-up and accelerate commercial-scale manufacturing of Tadekinig alfa.Contract Pharma Staff 10.29.20
-
Bioanalytical Services | Breaking News | CRO News | R&D
TherapeutAix Expands R&D Network
Adds CROs Alderley Analytical and Peak Proteins to address Pharmacokinetics and Pharmacodynamics challenges for clients.Contract Pharma Staff 10.29.20
-
Breaking News | Laboratory Testing | Promotions & Moves
Avomeen Names SVP of Lab Operations
Luke Miller brings 25 years of experience to the company.Contract Pharma Staff 10.29.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Catalent to Acquire Bone Therapeutics’ Cell Therapy Mfg. Facility
Expands cell therapy capabilities and advanced clinical and commercial supply, and creates an integrated European CoE.Contract Pharma Staff 10.29.20
-
Analytical Services | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News
Thermo Fisher, Symphogen Extend Development Pact
Will support the development of cancer treatments through optimization of protein characterization and quality monitoring mass spectrometry.Contract Pharma Staff 10.29.20
-
Breaking News | Clinical Trials | CRO News
BARDA Reselects ICON as Preferred Partner
Continues as part of BARDA’s exclusive Medical Countermeasures Clinical Studies NetworkContract Pharma Staff 10.29.20
-
Breaking News | Financial Reports
Financial Report: Gilead
Veklury (remdesivir) revenues were $873 million in the third quarter.Contract Pharma Staff 10.28.20
-
Breaking News | Industry News
Lilly, U.S. Govt. Enter Supply Pact for Bamlanivimab COVID-19 Treatment
Initial agreement is for 300,000 vials of the investigational neutralizing antibody with potential for purchase of an additional 650,000 vials.Contract Pharma Staff 10.28.20
-
Breaking News | Industry News
MilliporeSigma Awards Grant to Combined Therapeutics
Supports its nucleic acid platform that targets liver cancer with virotherapy.Contract Pharma Staff 10.28.20
- Lonza to Manufacture AstraZeneca's COVID-19 Long-Acting Antibody Combination
- Lilly, U.S. Govt. Enter Supply Pact for Bamlanivimab COVID-19 Treatment
- Stevanato, Catalent Partner to Expedite Equipment Installation
- Gilead’s Remdesivir Wins FDA Approval to Treat COVID-19
- LaunchWorks CDMO Approved to Provide Viral Transport Media
- Moderna Completes Enrollment in Phase III COVID-19 Vax Study
- Roche, Atea Pharma to Develop Potential Oral COVID-19 Treatment
- India Emerges as Hot Spot for Manufacturing COVID-19 Vaccines
- Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy
- AstraZeneca, U.S. Govt. Enter $486M COVID-19 Antibody Agreement
- Frontida BioPharm Names Steven Roese as Vice President, Quality
- Financial Report: Abbvie
- Lonza to Manufacture AstraZeneca's COVID-19 Long-Acting Antibody Combination
- Samsung Biologics Expands Global Footprint
- Syneos Health Agrees to Acquire Synteract
- AB2 Bio and WuXi Biologics Enter Collaboration
- TherapeutAix Expands R&D Network
- Financial Report: PPD
- Avomeen Names SVP of Lab Operations
- Catalent to Acquire Bone Therapeutics’ Cell Therapy Mfg. Facility
October 2020
- The Role of Electronic Monitoring in Maintaining Medication Adherence
- Understanding the Importance of Crystallization Processes
- Capsule Technology Trends
- A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility
- Regulatory Compliance Trends
- **ADVERTORIAL** Advanced Formulation Development by Design in the Context of Holistic Drug Production
- CEO Spotlight: Tim J. Mitchell, JD
- The Future of Serialization
- You Need Solutions, Digitization is the Answer
- Contract Manufacturing and Pandemic Resilience
Contract Service Directory
Search the Directories for A Company:
